LIN9 and NEK2 are core regulators of mitotic fidelity that can be therapeutically targeted to overcome taxane resistance

A significant therapeutic challenge for cancer patients is resistance to chemotherapies such as taxanes. Overexpression of LIN9, a transcriptional regulator of cell cycle progression, occurs in 65% of patients with triple negative breast cancer (TNBC), a disease commonly treated with these drugs. He...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Roberts, Melyssa S., Sahni, Jennifer M., Schrock, Morgan S., Piemonte, Katrina M., Weber-Bonk, Kristen L., Seachrist, Darcie D., Avril, Stefanie, Anstine, Lindsey J., Singh, Salendra, Sizemore, Steven T., Varadan, Vinay, Summers, Matthew K., Keri, Ruth A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7165041/
https://ncbi.nlm.nih.gov/pubmed/32054769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-19-3466
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados